NCT06463938View on ClinicalTrials.gov

A Clinical Trial to Compare Lasotronix Alone or in Combination With CPP-ACP to Treat DH

NARecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

May 12, 2024

Primary Completion Date

August 10, 2024

Study Completion Date

October 10, 2024

Conditions
Dentin SensitivityHypersensitivityCervical Lesion
Interventions
OTHER

Active comparator

CPP-ACP paste will be applied on exposed area

DEVICE

Experimental group

Lasotronix will be applied following its protocol

COMBINATION_PRODUCT

Combination of laser and paste

This group will receive the combination of above two treatments

BEHAVIORAL

Control group

this will be a control group

Trial Locations (1)

75330

RECRUITING

Dr Sanam Faheem, Karachi

All Listed Sponsors
lead

Dow University of Health Sciences

OTHER